Aldeyra Therapeutics IncNASDAQ:ALDX
- LAST PRICE5.5200
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots5.5200/ 9
- Ask / Lots5.5400/ 8
- Open / Previous Close5.5500 / 5.5200
- Day Range
- 52 Week Range
- Volume250,822
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ALDX |
|---|---|---|
| 09:32 ET | 11315 | 5.5315 |
| 09:33 ET | 798 | 5.532 |
| 09:35 ET | 2181 | 5.5509 |
| 09:37 ET | 300 | 5.57 |
| 09:39 ET | 8747 | 5.605 |
| 09:42 ET | 953 | 5.64 |
| 09:44 ET | 2930 | 5.61 |
| 09:46 ET | 300 | 5.57 |
| 09:48 ET | 100 | 5.565 |
| 09:50 ET | 528 | 5.58 |
| 09:51 ET | 2710 | 5.5465 |
| 09:55 ET | 264 | 5.54 |
| 10:00 ET | 1348 | 5.54 |
| 10:02 ET | 3989 | 5.53 |
| 10:04 ET | 850 | 5.4902 |
| 10:06 ET | 137 | 5.5 |
| 10:08 ET | 1000 | 5.5098 |
| 10:09 ET | 600 | 5.5 |
| 10:11 ET | 2500 | 5.52 |
| 10:13 ET | 649 | 5.51 |
| 10:15 ET | 8044 | 5.53 |
| 10:18 ET | 3300 | 5.51 |
| 10:20 ET | 5891 | 5.5 |
| 10:22 ET | 400 | 5.505 |
| 10:24 ET | 9544 | 5.545 |
| 10:26 ET | 700 | 5.54 |
| 10:27 ET | 921 | 5.555 |
| 10:29 ET | 2100 | 5.54 |
| 10:31 ET | 1007 | 5.53 |
| 10:33 ET | 3294 | 5.55 |
| 10:36 ET | 1984 | 5.56 |
| 10:38 ET | 5509 | 5.57 |
| 10:40 ET | 1343 | 5.5987 |
| 10:42 ET | 100 | 5.6 |
| 10:44 ET | 2650 | 5.6 |
| 10:47 ET | 240 | 5.595 |
| 10:49 ET | 100 | 5.6 |
| 10:54 ET | 349 | 5.59 |
| 10:56 ET | 600 | 5.6 |
| 10:58 ET | 324 | 5.6 |
| 11:00 ET | 1422 | 5.585 |
| 11:03 ET | 300 | 5.6 |
| 11:05 ET | 3475 | 5.5867 |
| 11:07 ET | 900 | 5.6 |
| 11:12 ET | 400 | 5.6 |
| 11:14 ET | 600 | 5.58 |
| 11:16 ET | 267 | 5.58 |
| 11:18 ET | 900 | 5.56 |
| 11:20 ET | 100 | 5.565 |
| 11:21 ET | 1500 | 5.55 |
| 11:23 ET | 5201 | 5.56 |
| 11:25 ET | 2823 | 5.58 |
| 11:34 ET | 300 | 5.56 |
| 11:36 ET | 1000 | 5.55 |
| 11:39 ET | 359 | 5.55 |
| 11:41 ET | 100 | 5.55 |
| 11:45 ET | 1500 | 5.56 |
| 11:48 ET | 220 | 5.56 |
| 11:50 ET | 900 | 5.55 |
| 11:54 ET | 100 | 5.545 |
| 11:56 ET | 1724 | 5.5387 |
| 11:57 ET | 1100 | 5.56 |
| 11:59 ET | 1000 | 5.57 |
| 12:01 ET | 974 | 5.5785 |
| 12:06 ET | 100 | 5.56 |
| 12:10 ET | 100 | 5.58 |
| 12:12 ET | 400 | 5.58 |
| 12:15 ET | 1165 | 5.58 |
| 12:17 ET | 100 | 5.58 |
| 12:19 ET | 100 | 5.58 |
| 12:21 ET | 1322 | 5.57 |
| 12:24 ET | 100 | 5.57 |
| 12:26 ET | 200 | 5.57 |
| 12:28 ET | 11039 | 5.55 |
| 12:30 ET | 200 | 5.545 |
| 12:32 ET | 1337 | 5.53 |
| 12:33 ET | 1000 | 5.525 |
| 12:35 ET | 440 | 5.53 |
| 12:37 ET | 1100 | 5.52 |
| 12:39 ET | 400 | 5.53 |
| 12:42 ET | 200 | 5.53 |
| 12:46 ET | 582 | 5.54 |
| 12:48 ET | 400 | 5.52 |
| 12:50 ET | 1054 | 5.53 |
| 12:53 ET | 236 | 5.5381 |
| 12:55 ET | 100 | 5.53 |
| 12:57 ET | 575 | 5.54 |
| 01:00 ET | 1097 | 5.535 |
| 01:02 ET | 500 | 5.53 |
| 01:04 ET | 200 | 5.5201 |
| 01:06 ET | 12293 | 5.49 |
| 01:09 ET | 100 | 5.47 |
| 01:11 ET | 2052 | 5.44 |
| 01:13 ET | 1500 | 5.435 |
| 01:15 ET | 1253 | 5.455 |
| 01:22 ET | 200 | 5.455 |
| 01:24 ET | 1888 | 5.43 |
| 01:26 ET | 472 | 5.425 |
| 01:29 ET | 4793 | 5.44 |
| 01:33 ET | 100 | 5.47 |
| 01:36 ET | 100 | 5.47 |
| 01:38 ET | 100 | 5.48 |
| 01:44 ET | 100 | 5.49 |
| 01:45 ET | 2149 | 5.51 |
| 01:49 ET | 500 | 5.52 |
| 01:51 ET | 100 | 5.51 |
| 01:58 ET | 702 | 5.525 |
| 02:00 ET | 170 | 5.5215 |
| 02:02 ET | 300 | 5.53 |
| 02:03 ET | 1671 | 5.53 |
| 02:14 ET | 3156 | 5.5115 |
| 02:25 ET | 155 | 5.5282 |
| 02:27 ET | 115 | 5.52 |
| 02:30 ET | 100 | 5.52 |
| 02:32 ET | 400 | 5.52 |
| 02:38 ET | 100 | 5.52 |
| 02:39 ET | 3500 | 5.51 |
| 02:41 ET | 700 | 5.52 |
| 02:43 ET | 100 | 5.53 |
| 02:45 ET | 100 | 5.53 |
| 02:48 ET | 1098 | 5.51 |
| 02:52 ET | 100 | 5.5 |
| 02:54 ET | 100 | 5.52 |
| 02:57 ET | 10393 | 5.49 |
| 02:59 ET | 200 | 5.49 |
| 03:01 ET | 1060 | 5.49 |
| 03:03 ET | 800 | 5.5 |
| 03:06 ET | 300 | 5.49 |
| 03:08 ET | 743 | 5.5 |
| 03:10 ET | 1000 | 5.5 |
| 03:14 ET | 1796 | 5.52 |
| 03:17 ET | 200 | 5.52 |
| 03:19 ET | 100 | 5.51 |
| 03:21 ET | 200 | 5.5 |
| 03:24 ET | 500 | 5.52 |
| 03:26 ET | 437 | 5.52 |
| 03:28 ET | 200 | 5.52 |
Oct 31, 2024
Aldeyra Therapeutics Selected to Present at the Disruptive Innovations Symposium during the OSN New York Retina 2024 Meeting, from 7:00AM ET on Thursday Oct 31, 2024 by Dow Jones
7:00AM ET on Thursday Oct 31, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Aldeyra Therapeutics Inc | 328.0M | -8.6x | --- |
Design Therapeutics Inc | 330.1M | -7.5x | --- |
Rezolute Inc | 323.3M | -4.4x | --- |
Nautilus Biotechnology Inc | 312.7M | -4.3x | --- |
enGene Holdings Inc | 349.3M | -1.7x | --- |
Biomea Fusion Inc | 296.4M | -2.0x | --- |
Company Information
Aldeyra Therapeutics, Inc. is a biotechnology company, which is engaged in discovering therapies designed to treat immune-mediated diseases. The Company's product candidates include reactive aldehyde species (RASP) modulators ADX-629, ADX-246, ADX-248, and chemically related molecules for the treatment of systemic and retinal immune-mediated diseases. Its pre-commercial product candidates are reproxalap, a RASP modulator for the potential treatment of dry eye disease and allergic conjunctivitis, and ADX-2191, a novel formulation of intravitreal methotrexate for the treatment of proliferative vitreoretinopathy and retinitis pigmentosa. Its ADX-629, is an orally administered RASP modulator in clinical development for atopic dermatitis, idiopathic nephrotic syndrome, moderate alcohol-associated hepatitis, chronic cough, and Sjogren-Larsson Syndrome. Its preclinical RASP platform includes ADX-246 and ADX-248 in development for metabolic, retinal diseases and systemic inflammatory diseases.
Contact Information
- Headquarters
- 131 HARTWELL AVENUE, SUITE 320LEXINGTON, MA, United States 02421
- Phone
- 781-761-4904
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Richard Douglas
- President, Chief Executive Officer, Director
- Todd Brady
- Principal Financial Officer and Principal Accounting Officer
- Michael Alfieri
- Chief Development Officer
- Stephen Machatha
- Independent Director
- Ben Bronstein
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $328.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 59.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.37 |
EPS | $-0.64 |
Book Value | $2.02 |
P/E Ratio | -8.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
